Q1 FY27 — 6 Aug 2026
Godrej Agrovet Limited Q1 FY27
Godrej Agrovet Limited reported a resilient Q1 FY27 with 10% consolidated sales growth to ₹2,852 crores, driven by strong performances in Animal Nutrition and Oil Palm. Astec LifeSciences achieved EBITDA breakeven, marking a significant recovery. However, the Crop Care segment faced headwinds from delayed monsoons, leading to a 16.2% revenue decline, while Dairy and Godrej Foods profitability was impacted by input cost inflation and geopolitical tensions. The company is actively pursuing strategic shifts in Oil Palm, Dairy, and Godrej Foods towards higher-margin, value-added products and B2C f
Read the full call






